AI-generated summary
The authors studied diabetic mice given 810 nm laser light to the left inguinal region for 7 days at two doses, comparing them with untreated controls. They report that the lower dose (20.4 J/cm2) lowered blood plasma fructosamine compared with controls, while the higher dose did not, and blood glucose did not differ significantly. The authors describe the findings as having the potential to ameliorate diabetes, based on this animal study.
- Participants
- 47
- Who or what was studied
- Diabetic mice
- Wavelengths
- 810 nm
- Limits stated in the abstract
- This is an animal study with a single 7-day treatment period, and the abstract reports no significant effect on blood glucose and a null result at the higher dose.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.